Angiotensin II in Refractory Septic Shock

Area of Science:

• Critical Care Medicine
• Pharmacology
• Physiology

Background:

• Refractory septic shock requires high-dose catecholamines, risking adverse effects like ischemia and arrhythmias.
• Angiotensin II (Ang II) is a vasopressor with potential to support blood pressure in critical illness.
• Limited clinical data exist on Ang II's efficacy in refractory septic shock.

Purpose of the Study:

• To review current literature on Angiotensin II administration in refractory septic shock.
• To differentiate between experimental and clinical findings regarding Ang II use.
• To explore Ang II's role in specific organ dysfunction and potential pitfalls in sepsis.

Main Methods:

• Literature review of experimental and clinical studies on Angiotensin II in septic shock.
• Analysis of Ang II's potential benefits and risks in critically ill patients.
• Consideration of Ang II's impact on organ dysfunction and microcirculation.

Main Results:

• Angiotensin II (Ang II) shows potential as an adjunct vasopressor in refractory septic shock.
• High-dose catecholamines, often required for refractory septic shock, carry significant risks.
• Further investigation is required to establish Ang II's role and optimal use.

Conclusions:

• Angiotensin II (Ang II) may reduce catecholamine requirements in refractory septic shock.
• Unresolved issues include optimal dosing, timing, and comparative efficacy against other vasopressors.
• Future studies should focus on Ang II's effects on microcirculation and specific organ dysfunction.